Organization · Venture Capital
Gore Range Capital
Gore Range Capital is a New York-based healthcare investment firm that focuses on science-led platforms in precision health, regenerative medicine, and skin health. The firm combines private equity operational discipline with venture capital strategies to support innovative healthcare solutions.
Overview
What Gore Range Capital does
What Gore Range Capital is
Gore Range Capital is a New York-based healthcare investment firm that focuses on science-led platforms in precision health, regenerative medicine, and skin health. The firm combines private equity operational discipline with venture capital strategies to support innovative healthcare solutions.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- May 2, 2026
Official channels
Find Gore Range Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Gore Range Capital as a funder
Investment thesis
Gore Range invests in healthcare platforms designed to improve functional health, quality of life, and long-term wellbeing, focusing on innovations that combine scientific discovery with clinical and commercial scalability.
Focus narrative
Gore Range Capital invests in companies that are developing next-generation healthcare solutions aimed at addressing the root causes of aging, chronic disease, and functional decline. The firm emphasizes innovations that integrate scientific discovery with clinical and commercial scalability, particularly in the area of skin health, which serves as a biological gateway to health and longevity.
Value beyond capital
Gore Range Capital provides strategic, financial, and clinical guidance to its portfolio companies, leveraging its expertise in healthcare science and operational discipline to support their development, regulatory progress, and commercialization.
Focus and fit
- Stages
- Seed · Growth Equity · Series A · Series B
- Sectors
- Healthcare · Biotech · Longevity · Regenerative Medicine · Digital Health · Medical Devices
- Regions
- United States · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Novaestiq
Portfolio context
Notable portfolio companies include Novaestiq, which is developing injectable hyaluronic-acid gels and was sold to Waldencast; Palvella Therapeutics, a clinical-stage biopharma company focused on therapies for rare genetic skin diseases; and Sagesse Bio, which is developing SGY-101 for targeted fat reduction.
Common questions
What to know about Gore Range Capital
Upseed classifies Gore Range Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 2, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.